Literature DB >> 8692492

Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers.

M Ekman1, M Fjälling, S Friman, S Carlson, R Volkmann.   

Abstract

Hepatobiliary scintigraphy with 99Tc(m)-diethyl-iodo-HIDA (IODIDA), an iminodiacetic acid derivative, is used to assess hepatocyte function and to visualize the hepatobiliary system. The aim of this study was to evaluate whether it is possible to describe liver function by calculating the clearance rate of IODIDA from the blood. Clearance rate was evaluated in 18 liver transplant patients (28 studies) and 11 healthy volunteers (11 studies). Two different clearance rates were calculated: the clearance of IODIDA from the blood due to liver uptake and the total clearance of IODIDA from the blood due to all possible routes of elimination. Both for the healthy controls and the liver transplant patients, there was an excellent correlation between these two methods (r = 0.92 and r = 0.93, respectively), indicating that the liver is the only essential pathway for elimination of IODIDA from the blood. The difference in clearance rate between healthy controls and liver transplant patients was highly significant (P < 0.01), corresponding to the clinical condition of the two groups. We conclude that the clearance rate of IODIDA, based on a simple measurement from the time-activity curve derived from a blood pool region of interest, is a reliable test of liver function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692492     DOI: 10.1097/00006231-199603000-00011

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  20 in total

1.  A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in 90Y Radioembolization.

Authors:  Sandra van der Velden; Manon N G J A Braat; Tim A Labeur; Mike V Scholten; Otto M van Delden; Roelof J Bennink; Hugo W A M de Jong; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

2.  Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.

Authors:  Kasia P Cieslak; Roelof J Bennink; Wilmar de Graaf; Krijn P van Lienden; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-07-25       Impact factor: 3.647

3.  Liver function declines with increased age.

Authors:  Kasia P Cieslak; Onno Baur; Joanne Verheij; Roelof J Bennink; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-06-20       Impact factor: 3.647

4.  Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.

Authors:  Boris Guiu; François Quenet; Laure Escal; Frédéric Bibeau; Lauranne Piron; Philippe Rouanet; Jean-Michel Fabre; Eric Jacquet; Alban Denys; Pierre-Olivier Kotzki; Daniel Verzilli; Emmanuel Deshayes
Journal:  Eur Radiol       Date:  2017-01-18       Impact factor: 5.315

5.  Imaging-based evaluation of liver function: comparison of ⁹⁹mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI.

Authors:  Dominik Geisel; Lutz Lüdemann; Vera Fröling; Maciej Malinowski; Martin Stockmann; Annekathrin Baron; Bernhard Gebauer; Daniel Seehofer; Vikas Prasad; Timm Denecke
Journal:  Eur Radiol       Date:  2014-12-02       Impact factor: 5.315

6.  Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors.

Authors:  Peter Gunvén; Eduard Jonas; Henric Blomgren; Eva Rutkowska; Kristin Karlsson; Ingmar Lax; Seymour Levitt
Journal:  Med Oncol       Date:  2010-05-19       Impact factor: 3.064

Review 7.  Optimization of the future remnant liver: review of the current strategies in Europe.

Authors:  Riccardo Memeo; Maria Conticchio; Emmanuel Deshayes; Silvio Nadalin; Astrid Herrero; Boris Guiu; Fabrizio Panaro
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

8.  Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection.

Authors:  Jacomina W van den Esschert; Wilmar de Graaf; Krijn P van Lienden; Olivier R Busch; Michal Heger; Otto M van Delden; Dirk J Gouma; Roelof J Bennink; Johan S Laméris; Thomas M van Gulik
Journal:  J Gastrointest Surg       Date:  2009-05-28       Impact factor: 3.452

9.  Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [99mTc]TcMebrofenin.

Authors:  Kathy P Willowson; Geoffrey P Schembri; Elizabeth J Bernard; David Lh Chan; Dale L Bailey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-20       Impact factor: 9.236

Review 10.  Current Modalities for the Assessment of Future Remnant Liver Function.

Authors:  Fadi Rassam; Pim B Olthof; Roelof J Bennink; Thomas M van Gulik
Journal:  Visc Med       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.